ArticleZeitschrift fur Rheumatologie2013

[Adalimumab for early rheumatoid arthritis - Chances and risks: Initial analyses of the OPTIMA study].

M SchmalzingPubMed ↗Publisher ↗

No numbers read from the abstract.